Skip to content

Remote rehabilitation after intensive care

Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge: a randomised controlled assessor-blind clinical and cost-effectiveness trial with an internal pilot (iRehab)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11266403
Enrollment
428
Registered
2022-07-26
Start date
2022-11-18
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Any condition requiring admission to intensive care and 48 hours of invasive mechanical ventilation Other

Interventions

Six-week remote multi-component, individualised, rehabilitation intervention incorporating: weekly symptom management
psychological support
and peer support and information compared to standard care Half of the participants will be randomised to receive standard NHS care and half will receive the 6-week iRehab programme. The randomisatio

Sponsors

University of Ulster
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adults within 12 weeks of hospital discharge after treatment of a critical illness requiring ICU care and mechanical ventilation for =48 hours

Exclusion criteria

Exclusion criteria: 1. Declined consent or unable to provide consent 2. Previous randomisation into the present trial 3. Participating in another rehabilitation or self-management support trial 4. Contra-indication to exercise 5. Severe mental health problems that preclude participation in a group intervention 6. Discharged to a rehabilitation unit, or care home with/without nursing care 7. Prisoners

Design outcomes

Primary

MeasureTime frame
Health-related quality of life (HRQoL) measured using EQ-5D-5L at 8 weeks

Secondary

MeasureTime frame
1. Physical function measured using 30-sec Sit-To-Stand at 8 weeks and 6 months 2. Illness perceptions measured using Brief Illness Perceptions Questionnaire at 8 weeks and 6 months 3. Fatigue measured using Functional Assessment of Chronic Illness therapy at 8 weeks and 6 months 4. Anxiety and depression measured using the Hospital Anxiety and Depression Scale (HADS) at 8 weeks and 6 months 5. Health and social care use measured using the healthcare and social care utilisation questionnaire at 8 weeks and 6 months 6. Safety measured using data on serious adverse events collected at 8 weeks and 6 months Added 10/10/2023: 7. Intervention acceptability measured using a Theoretical Framework Acceptability Questionnaire (TFAQ) at 8 weeks

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 28, 2026